Timeline
RUA Life Sciences narrows loss and swings to positive EBITDA in first half
Health & Bio Today: Creo Medical raises £5.5m and sells 49% stake in unit, Rua Life Sciences
RUA Life Sciences sees higher first half revenue, and earnings breakeven
RUA Life Sciences spins out RUA Structural Heart and secures funding
More in Telecoms
Vodafone Group shares soar after stake sale to Xavier Niel
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.